Enhancing current human immunodeficiency virus/hepatitis B and human immunodeficiency virus/hepatitis C virus co-infection management
[...]screening HIV in HBV or HCV patients provides an opportunity to diagnose and manage the infection at an earlier stage. [...]routine HIV screening is strongly recommended among newly diagnosed HBV and HCV patients. The higher risk of all-cause death and non-liver-related cancers in HIV/HCV co-in...
Saved in:
Published in | Chinese medical journal Vol. 133; no. 23; pp. 2890 - 2891 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
China
Lippincott Williams & Wilkins
05.12.2020
Lippincott Williams & Wilkins Ovid Technologies Department of Infectious Diseases, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510630, China Wolters Kluwer |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | [...]screening HIV in HBV or HCV patients provides an opportunity to diagnose and manage the infection at an earlier stage. [...]routine HIV screening is strongly recommended among newly diagnosed HBV and HCV patients. The higher risk of all-cause death and non-liver-related cancers in HIV/HCV co-infected patients can be explained by chronic inflammation and immune system dysregulation due to HIV infection and high-risk behaviors such as tobacco smoking and alcohol consumption in the co-infected subjects. [4] PLWH co-infected with HBV or HCV are at markedly increased risk for ESLD compared with those monoinfected by HIV. Since the introduction of combination ART, morbidity, and mortality were significantly reduced in PLWH. |
---|---|
Bibliography: | SourceType-Scholarly Journals-1 ObjectType-Correspondence-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0366-6999 2542-5641 2542-5641 |
DOI: | 10.1097/CM9.0000000000001149 |